Seratrodast (Standard)
Seratrodast (Standard) is the analytical standard of Seratrodast. This product is intended for research and analytical applications. Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].
Product Specifications
CAS Number
112665-43-7
Product Name Alternative
AA 2414 (Standard)
UNSPSC
12352005
Hazard Statement
H361
Target
Ferroptosis; JNK; MDM-2/p53; Prostaglandin Receptor; Reactive Oxygen Species (ROS) ; Reference Standards
Type
Reference Standards
Related Pathways
Apoptosis; GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; Others
Field of Research
Cancer; Endocrinology; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/seratrodast-standard.html
Purity
98.17
Smiles
CC(C1=O)=C(C(C(C)=C1C)=O)C(C2=CC=CC=C2)CCCCCC(O)=O
Molecular Formula
C22H26O4
Molecular Weight
354.44
Precautions
H361
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, sealed storage, away from light and moisture
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
MAGE A1 (MA454), CF405S conjugate, 0.1mg/mL
Cytokeratin, HMW (AE-3), CF640R conjugate, 0.1mg/mL
